临床上有没有尿检正常而血肌酐升高的情况?

2019-02-18 李青大夫 李青科普

我前几天在医院体检,尿检查出隐血+-,红细胞1.3,尿蛋白阴性,医生说不要紧,问题不大,没让做肾功能检查。我想问下像我上面这种情况需要进一步做肾功吗?临床上有没有尿检基本正常肾功能却不正常的的情况?比如说尿检基本正常,肾功却肌酐高?

这是一个粉丝的咨询:我前几天在医院体检,尿检查出隐血+-,红细胞1.3,尿蛋白阴性,医生说不要紧,问题不大,没让做肾功能检查。我想问下像我上面这种情况需要进一步做肾功吗?临床上有没有尿检基本正常肾功能却不正常的的情况?比如说尿检基本正常,肾功却肌酐高?

这位粉丝的尿检是正常的,估计她还是担心自己的肾脏有问题,所以有了以上咨询。

一般来说,常见的肾脏病最早出现蛋白尿、血尿等尿检异常,当病情严重到一定程度时,会出现肾功能下降,表现为血肌酐升高。但是,临床上尿检正常而血肌酐升高的情况也并不少见。

一、蛋白尿是怎么产生的?

简单的说,肾脏由肾小球、肾小管和肾间质组成。

肾小球的主要功能是滤过功能,肾小管的主要功能是回吸收功能,肾间质的主要功能是组织支撑和电解质调节等功能。

血液每天流经肾脏,经肾小球滤过后,代谢废物(大多是小分子物质)随尿排出体外,而血液中的红细胞和大分子物质比如蛋白质、脂肪、糖等不会被滤出。

正常情况下,也有少量小分子蛋白质、糖通过肾小球滤过,但都被肾小管回吸收,所以,尿中既没有红细胞,尿糖和尿蛋白也都是阴性。

肾小球损伤后,红细胞漏出,更多的蛋白质和糖也漏出来,超出了肾小管的回吸收能力,就形成血尿、蛋白尿、糖尿等。所以说,血尿、蛋白尿是肾小球损伤的结果。

当然,肾小管损伤后,对正常滤过的小分子蛋白质无法回吸收,也可能出现微量蛋白尿。

二、血肌酐高是怎么形成的?

长期的疾病导致肾小球不断受损,肾小球的结构遭到严重破坏,滤过功能大大下降。人体两个肾脏大约有240万个肾小球,当一半多的肾小球遭破坏后,小分子的代谢废物比如肌酐、尿素氮、尿酸等的排泄都出现问题,就出现血肌酐升高,这就是慢性肾功能衰竭。

三、哪些情况会出现尿检正常而血肌酐升高的情况呢?

肾小球疾病的主要特点是蛋白尿、血尿,而非肾小球疾病就不一定出现蛋白尿,或者蛋白尿比较轻微。比如:

1、缺血性肾脏病:

我们都知道缺血性心脏病(冠心病)、缺血性脑病(脑梗),其实还有缺血性肾脏病,严格的说,三者是一个病,都是动脉粥样硬化。

肾动脉粥样硬化后肾动脉狭窄,肾脏长期缺血萎缩,就会出现血肌酐升高。但这种疾病的肾小球滤过膜没有明显损伤,所以一般不会出现蛋白尿,患者血肌酐都比较高了,尿检还是正常的。

发现下列情况,高度怀疑有缺血性肾脏病:

55岁以后的严重高血压

原本控制稳定的血压出现了波动;

双肾大小相差超过1cm;

不明原因的血肌酐升高;

不明原因的心衰

不明原因的肺水肿。

缺血性肾脏病的治疗,除降压、降脂外,早期也可以做肾动脉支架治疗。

2、痛风性肾病

长期高尿酸血症,尿酸盐沉积在肾小管和肾间质引起肾脏损伤,主要导致肾小管间质纤维化,肾小球病变相对较轻,所以血肌酐升高了但尿蛋白阴性或者轻度蛋白尿。

高尿酸血症出现较早,尿酸往往超过540μmol/L,常伴有痛风性关节炎、痛风石、尿酸性肾结石等。

降尿酸治疗是最有效的治疗措施。

3、慢性肾小管间质肾炎(药物性肾损害):

解热镇痛药和许多中药,主要损害肾小管和肾间质,肾小球的病变较轻,所以没有蛋白尿或者尿蛋白轻微。

有长期服用中药或者解热镇痛药的病史,血肌酐缓慢升高。

停止服用可疑的药物,部分患者可以使用激素治疗。

4、高血压性肾脏病:

长期高血压导致肾内小动脉硬化。肾小管损害早于肾小球损害,所以高血压性肾脏病早期表现为肾小管损伤,尿浓缩功能下降,表现为夜尿增多,尿比重变轻。早期没有蛋白尿,血肌酐升高甚至早于蛋白尿的出现,中晚期可以出现蛋白尿,但尿蛋白定量很少超过1g/d,可有镜下血尿及管型尿。

患者年龄多在40~50 岁以上,高血压病史5~10年以上,常有高血压的其他并发症比如冠心病、脑梗等。

强化降压治疗,首选沙坦类或者普利类降压药,联合地平类降压药、利尿剂等。严格控制血压是高血压性肾脏病最有效的治疗。

5、多囊肾:

是一种遗传病,表现为双侧肾脏多个大小不一的囊肿,并逐渐增大,双侧肾脏肿大,继发肾功能损害,血肌酐升高,血压明显升高,最终发展到尿毒症,或者因为严重高血压导致的心、脑并发症去世。发病年龄越早,病情越重。

血肌酐升高,蛋白尿不明显或者阴性。

除了肾脏多囊以外,肝脏、脾脏、甲状腺等实质脏器也出现多囊,而且家族中多人发病。

没有特别有效的治疗方法,严格控制血压,延缓肾损害,避免高血压的心脑血管并发症。早期患者可以服用托伐普坦治疗,可延缓囊肿的生长。

总之,对长期高血压、高脂血症、抽烟、高尿酸血症患者,怀疑有肾脏损伤者,或者多囊肾患者,除检查尿常规之外,还要进行肾功能及肾脏超声检查,避免漏诊。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-03-13 12519a29m70暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-19 俅侠
  3. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-19 ying_wu
  4. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-18 SCI我的梦

    谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-18 深海的鱼

    学习学习学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=362593, encodeId=5d8636259344, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54a42539057, createdName=12519a29m70暂无昵称, createdTime=Wed Mar 13 20:26:07 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293424, encodeId=c55212934249f, content=<a href='/topic/show?id=1d44810e5f7' target=_blank style='color:#2F92EE;'>#肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81075, encryptionId=1d44810e5f7, topicName=肌酐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428889, encodeId=eb4414288896a, content=<a href='/topic/show?id=afdb89895bb' target=_blank style='color:#2F92EE;'>#血肌酐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89895, encryptionId=afdb89895bb, topicName=血肌酐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79064143263, createdName=ying_wu, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511530, encodeId=efbc1511530c6, content=<a href='/topic/show?id=a2724e42925' target=_blank style='color:#2F92EE;'>#尿检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47429, encryptionId=a2724e42925, topicName=尿检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=207610348585, createdName=ms2999106592497887, createdTime=Tue Feb 19 15:51:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360909, encodeId=d1b7360909a3, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=f52d2514454, createdName=SCI我的梦, createdTime=Mon Feb 18 08:47:09 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360902, encodeId=fd0d360902f5, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Mon Feb 18 07:17:08 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360895, encodeId=c25c360895f4, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Mon Feb 18 06:36:20 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-18 txqjm

    谢谢了,学习

    0

相关资讯

新型尿检方法诊断胰腺癌准确率达90%!

随着医学的发展,人们已经意识到了疾病检查方法与治疗手段同样重要。这个道理在肿瘤的治疗和预防中显得尤为重要。据此,长期以来世界各国的科学家们都致力于开发新的肿瘤检测方法。 最近来自英国和西班牙的科学家开发出了一种新型尿检方法有望提高检测胰腺癌的效率,这一结果也已经被发表在Clinical Cancer Research。 胰腺癌是一种恶性肿瘤,当现有检查手段确诊胰腺癌时,这种疾病往往已经发展

日立将开展通过尿检判断是否患癌的实验

据日本《朝日新闻》4月16日报道,日立制作所和日本名古屋大学医学部附属医院自本月起将开始进行实证试验,通过尿液检查判断是否罹患癌症。这在全球尚属首次。

肾内科常见尿液检查的临床意义,你知道多少?

肾脏内科常用的尿液检查主要包括尿常规+沉渣镜检、尿红细胞相位、肾脏早期损伤指标(白蛋白/肌酐比值、NAG酶、α1微球)、尿培养、24小时尿液检查(尿蛋白定量、尿离子定量、尿酸定量、尿轻链定量、肌酐清除率)、尿渗透压、尿蛋白电泳、尿免疫固定电泳。尽量清晨空腹留取尿标本,并避开月经期,也就是说要在月经结束3天以后,避免污染标本,导致检查结果不准确或假阳性。

尿检也能查CT/NG!NAATs技术保障女性生殖健康

近日,在第十一届中华女性生殖道感染峰会“白云会”期间,清华长庚医院妇产科主任廖秦平教授、首都医科大学附属北京妇产医院妇科主任刘朝晖教授及中南大学湘雅三医院妇产科主任薛敏教授针对临床常见的沙眼衣原体(CT)、淋病奈瑟菌(NG)感染及其并发症防治问题展开了积极讨论。

利用合成的细菌从尿液中检测到糖尿病和癌症

研究人员设计出了分别能在尿中无创检测糖尿病和癌症的细菌。由两个独立的小组所进行的这些研究为在诊所中用人工合成细菌作为诊断工具打下了基础。合成生物学在设计活细胞来发挥特殊功用上已经取得了进展;这些特殊功用包括从生产或输送药物至在体内探查疾病及在环境中探查毒素。细胞(通常是细菌)能以目前诊断装置所不能的方式对它们的环境做出反应和适应。但是,由于它们在复杂的患者样本中有着不可靠的行为和不良的信号检测,因

Lancet:快速尿检结核是否能使HIV患者获益?

HIV患者中结核菌感染是主要的致死因素,然而HIV患者中结核易在体内播散,症状缺乏特异性,诊断流程亟待优化。